1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Pharmaceutical Drug Delivery Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Pharmaceutical Drug Delivery Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Pharmaceutical Drug Delivery Market Regional Analysis
6.2 North America Pharmaceutical Drug Delivery Market Revenue 2017-2027 (US$ Million)
6.3 North America Pharmaceutical Drug Delivery Market Forecast Analysis
7. North America Pharmaceutical Drug Delivery Market Analysis – by Route of Administration
7.1 Oral Drug Delivery
- 7.1.1 Overview
- 7.1.2 Oral Drug Delivery: North America Pharmaceutical Drug Delivery Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.2 Injectable Drug Delivery
- 7.2.1 Overview
- 7.2.2 Injectable Drug Delivery: North America Pharmaceutical Drug Delivery Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.3 Topical Drug Delivery
- 7.3.1 Overview
- 7.3.2 Topical Drug Delivery: North America Pharmaceutical Drug Delivery Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.4 Ocular Drug Delivery
- 7.4.1 Overview
- 7.4.2 Ocular Drug Delivery: North America Pharmaceutical Drug Delivery Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.5 Pulmonary Drug Delivery
- 7.5.1 Overview
- 7.5.2 Pulmonary Drug Delivery: North America Pharmaceutical Drug Delivery Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.6 Nasal Drug Delivery
- 7.6.1 Overview
- 7.6.2 Nasal Drug Delivery: North America Pharmaceutical Drug Delivery Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.7 Transmucosal Drug Delivery
- 7.7.1 Overview
- 7.7.2 Transmucosal Drug Delivery: North America Pharmaceutical Drug Delivery Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.8 Implantable Drug Delivery
- 7.8.1 Overview
- 7.8.2 Implantable Drug Delivery: North America Pharmaceutical Drug Delivery Market – Revenue and Forecast, 2017-2027 (US$ Million)
8. North America Pharmaceutical Drug Delivery Market Analysis – by Application
8.1 Infectious Diseases
- 8.1.1 Overview
- 8.1.2 Infectious Diseases: North America Pharmaceutical Drug Delivery Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.2 Cancer
- 8.2.1 Overview
- 8.2.2 Cancer: North America Pharmaceutical Drug Delivery Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.3 Cardiovascular Diseases
- 8.3.1 Overview
- 8.3.2 Cardiovascular Diseases: North America Pharmaceutical Drug Delivery Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.4 Diabetes
- 8.4.1 Overview
- 8.4.2 Diabetes: North America Pharmaceutical Drug Delivery Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.5 Respiratory Diseases
- 8.5.1 Overview
- 8.5.2 Respiratory Diseases: North America Pharmaceutical Drug Delivery Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.6 Central Nervous System Disorders
- 8.6.1 Overview
- 8.6.2 Central Nervous System Disorders: North America Pharmaceutical Drug Delivery Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.7 Autoimmune Diseases
- 8.7.1 Overview
- 8.7.2 Autoimmune Diseases: North America Pharmaceutical Drug Delivery Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.8 Other Diseases
- 8.8.1 Overview
- 8.8.2 Other Diseases: North America Pharmaceutical Drug Delivery Market – Revenue and Forecast, 2017-2027 (US$ Million)
9. North America Pharmaceutical Drug Delivery Market Analysis – by End User
9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Hospitals: North America Pharmaceutical Drug Delivery Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.2 Home Care Settings
- 9.2.1 Overview
- 9.2.2 Home Care Settings: North America Pharmaceutical Drug Delivery Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.3 ASC/Clinics
- 9.3.1 Overview
- 9.3.2 ASC/Clinics: North America Pharmaceutical Drug Delivery Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.4 Other End Users
- 9.4.1 Overview
- 9.4.2 Other End Users: North America Pharmaceutical Drug Delivery Market – Revenue and Forecast, 2017-2027 (US$ Million)
10. North America Pharmaceutical Drug Delivery Market – North America Analysis
10.1 Overview
10.2 North America
- 10.2.1 North America Pharmaceutical Drug Delivery Market Breakdown, by Key
Country, 2020 and 2027 (%)
- 10.2.1.1 North America Pharmaceutical Drug Delivery Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 US:
North America Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.1.1 US: North America Pharmaceutical Drug Delivery Market Breakdown, by Route of Administration
- 10.2.1.1.2 US: North America Pharmaceutical Drug Delivery Market Breakdown, by Application
- 10.2.1.1.3 US: North America Pharmaceutical Drug Delivery Market Breakdown, by End User
- 10.2.1.2 Canada:
North America Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.2.1 Canada: North America Pharmaceutical Drug Delivery Market Breakdown, by Route of Administration
- 10.2.1.2.2 Canada: North America Pharmaceutical Drug Delivery Market Breakdown, by Application
- 10.2.1.2.3 Canada: North America Pharmaceutical Drug Delivery Market Breakdown, by End User
- 10.2.1.3 Mexico :
North America Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.3.1 Mexico : North America Pharmaceutical Drug Delivery Market Breakdown, by Route of Administration
- 10.2.1.3.2 Mexico : North America Pharmaceutical Drug Delivery Market Breakdown, by Application
- 10.2.1.3.3 Mexico : North America Pharmaceutical Drug Delivery Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 3M
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Antares Pharma
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 BD
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Pfizer Inc.
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Johnson & Johnson Services, Inc.
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations
Get Free Sample For North America Pharmaceutical Drug Delivery Market
